ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 379-388

  Kusner, David J ^a,b   Adams, Juan ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBIOTIC AGENT; PHOSPHOLIPASE D; PURINE RECEPTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUBERCULOSIS;

EID: 0033957426     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.379     Document Type: Article

References (59)

1. Smith, P. E., and A. R. Moss. 1994. Epidemiology of tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control. B. R. Bloom, ed. ASM, Washington, D.C., pp. 47-60.
2. Kent, J. H. 1993. The epidemiology of multidrug-resistant tuberculosis in the United States. Med. Clin. N. Am. 77:1391.
3. Parsons, L. M., J. R. Driscoll, H. W. Taber, and M. Salfinger. 1997. Drug resistance in tuberculosis. Infect. Dis. Clin. N. Am. 11:905.
4. Bradford, W. Z., and C. L. Daley. 1998. Multiple drug-resistant tuberculosis. Infect. Dis. Clin. N. Am. 12:157.
5. Ellner, J. J. 1997. Regulation of the human immune response during tuberculosis. J. Lab. Clin. Med. 130:469.
6. Dannenberg, A. M., Jr., and G. A. W. Rook. 1994. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses - dual mechanisms that control bacillary multiplication. In Tuberculosis: Pathogenesis, Protection, and Control. B. R. Bloom, ed. ASM, Washington, D.C., pp. 459-484.
7. Denis, M. 1991. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin. Exp. Immunol. 84:200.
8. Crowle, A. J., and E. J. Ross. 1989. Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun. 57: 840.
9. Rook, G. A. W., J. Steele, M. Ainsworth, and B. R. Champion. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant γ-interferon on human monocytes and murine peritoneal macrophages. Immunology 59:333.
10. 3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun. 55:2945.
11. 3, γ interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57:159.
12. Douvas, G. S., D. L. Looker, A. E. Vatter, and A. J. Crowle. 1985. γ Interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun. 50:1.
13. Silver, R. F., Q. Li, and J. J. Ellner. 1998. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor α but not with evasion of lymphocyte-dependent monocyte effector functions. Infect. Immun. 66:1190.
14. Baleewicz-Sablinska, M. K., J. Keane, H. Kornfeld, and H. G. Remold. 1998. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J. Immunol. 161:2636.
15. Byrd, T. F. 1997. Tumor necrosis factor-α promotes growth of virulent Mycobacterium tuberculosis in human monocytes: iron-mediated growth suppression is correlated with decreased release of TNFα from iron-treated infected monocytes. J. Clin. Invest. 99:2518.
16. Rockett, K. A., R. Brookes, I. Udalova, V. Vidal, A. V. S. Hill, and D. Kwiatkowski. 1998. 1,25-dihydroxyvitamin D-3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect. Immun. 66:5314.
17. 3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macrophages. Am. Rev. Respir. Dis. 139:549.
18. 2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265:C577.
19. 7) receptors. Immunity 7:433.
20. Molloy, A., P. Laochumroonvorapong, and G. Kaplan. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J. Exp. Med. 180:1499.
21. Cohn, D. L. 1997. Use of the bacille Calmette-Guerin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine. Am. J. Med. Sci. 313:372.
22. O'Brien, K. L., A. J. Ruff, M. A. Louis, J. Desormeaux, D. J. Joseph, M. McBrien, J. Coberly, R. Boulos, and N. A. Halsey. 1995. Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature. Pediatrics 95:414.
23. 2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16:524.
24. 7-independent mechanism. J. Immunol. 163:558.
25. 1). Science 272:735.
26. 1 cloning and expression of a human cDNA. J. Biol. Chem. 272:5482.
27. 2Z purinergic receptors in BAC1.2F5 macrophages. J. Biol. Chem. 267:23664.
28. 2Z purinergic receptors in BAC1.2F5 macrophages; product inhibition of phospholipase D enzyme activity. J. Biol. Chem. 268:15571.
29. Fukami, K., and T. Takenawa. 1992 Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated BALB/c 3T3 cells is a potential mitogenic signal. J. Biol. Chem. 267:10988.
30. Qualliotine-Mann, D., D. E. Agwu, M. D. Ellenburg, C. E. McCall, and L. C. McPhail. 1993. Phosphatidic acid and diacylglycerol synergize in a cell-free system for activation for NADPH oxidase from human neutrophils. J. Biol. Chem. 268:23843.
31. 4, and formyl-methionyl-leucyl-phenylalanine in rabbit neutrophils: phospholipase D activation is involved in enzyme release. J. Immunol. 146:3536.
32. 2-purinergic-and chemotactic peptide-receptor agonists is induced during granulocytic differentiation of HL-60 cells. J. Clin. Invest. 88:45.
33. Kusner, D. J., C. F. Hall, and L. S. Schlesinger. 1996. Activation of phospholipase D is tightly coupled to the phagocytosis of Mycobacterium tuberculosis or opsonized zymosan by human macrophages. J. Exp. Med. 184:585.
34. Fallman, M., M. Gullberg, C. Hellberg, and T. Andersson, 1992. Complement receptor-mediated phagocytosis is associated with accumulation of phosphatidylcholine-derived diglyceride in human neutrophils. J. Biol. Chem. 267:2656.
35. Olson, S. C., and J. D. Lambeth. 1996. Biochemistry and cell biology of phospholipase D in human neutrophils. Chem. Phys. Lipids 80:3.
36. Exton, J. H. 1997. Phospholipase D: enzymology, mechanisms of regulation, and function. Physiol. Rev. 77:303.
37. Nakagawara, A., and C. F. Nathan. 1983. A simple method for counting adherent cells: application to cultured human rnonocytes and multinucleated giant cells. J. Immunol. Methods 56:261.
38. 7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-γ in the human THP-1 monucytic cell line. J. Immunol. 157:5627.
39. 7 nucleotide receptor expression by pro-and anti-inflammatory stimuli in THP-1 monocytes. J. Leukocyte Biol. 64:265.
40. Paul, S., P. Laochumroonvorapong, and G. Kaplan. 1996. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J. Infect. Dis. 174:105.
41. Majeed, M., N. Perskvist, J. D. Ernst, K. Orselius, and O. Stendahl. 1998. Roles of calcium and annexins in phagocytosis and elimination of an attenuated strain of Mycobacterium tuberculosis in human neutrophils. Microb. Pathog. 24:309.
42. Schlesinger, L. S., C. G. Bellinger-Kawahara, N. R. Payne, and M. A. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144: 2771.
43. Kusner, D. J., S. J. Schomisch, and G. R. Dubyak. 1993. ATP-induced potentiation of G-protein-dependent phospholipase D activity in a cell-free system from U937 promonocytic leukocytes. J. Biol. Chem. 268:19973.
44. Brown, H. A., S. Gutowski, C. R. Moomaw, C. Slaughter, and P. C. Sternweis. 1993. ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity. Cell 75:1137.
45. Colton, T. 1974. Regression and correlation. In Statistics in Medicine. Little, Brown and Co., Boston, pp. 189-218.
46. Durrbaum-Landmann, I., J. Gercken, H. D. Flad, and M. Ernst. 1996. Effect of in vitro infection of human monocytes with low numbers of Mycobacterium tuberculosis bacteria on monocyte apoptosis. Infect. Immun. 64:5384.
47. Clemens, D. L., and M. A. Horwitz. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181:257.
48. Clemens, D. L., and M. A. Horwitz. 1996. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J. Exp. Med. 184:1349.
49. Valway, S. E., M. P. Sanchez, T. F. Shinnick, I. Orme, T. Agerton, D. Hoy, J. S. Jones, H. Westmoreland, and I. M. Onorato. 1998. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 338:633.
50. 2Z receptor. J. Biol. Chem. 268:8199.
51. Kanaho, Y., Y. Nakai, M. Katoh, and Y. Nozawa. 1993. The phosphatase inhibitor 2,3-diphosphoglycerate interferes with phospholipase D activation in rabbit neutrophils. J. Biol. Chem. 268:12492.
52. Kondo, T., H. Inui, F. Konishi, and T. Inagami. 1992. Phospholipase D mimics platelet-derived growth factor as a competence factor in vascular smooth muscle cells. J. Biol. Chem. 267:23609.
53. Ha, K. S., and J. H. Exton. 1997. Activation of actin polymerization by phosphatidic acid derived from phosphatidylcholine in IIC9 fibroblasts. J. Cell Biol. 123:1789.
54. 7 receptor: a pivotal role in inflammation and immunomodulation. Drug Dev. Res. 45:207.
55. Melendez, A., R. A. Floto, D. J. Gillooly, M. M. Harnett, and J. M. Allen. 1998. Fc(γ)RI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 273:9393.
56. Hammond, S. M., Y. Altshuller, T.-C. Sung, S. A. Rudge, K. Rose, J. Engebrecht, A. J. Morris, and M. A. Frohman. 1995. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J. Biol. Chem. 270:29640.
57. Colley, W. C., T.-C. Sung, R. Roll, J. Jenco, S. M. Hammond, Y. Altshuller, D. Bar-Sagi, A. J. Morris, and M. A. Frohman. 1997. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7:191.
58. Stenger, S., R. J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J. P. Rosat, A. Sette, M. B. Brenner, S. A. Porcelli, B. R. Bloom, and R. L. Modlin. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276:1684.
59. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, et al. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121.